the NNMT inhibitor literature does not, with every published in-vivo study of 5-Amino-1MQ conducted in rodents and no NNMT inhibitor approved in any jurisdiction
They recognize that clinical trials showed modest effects (average 2.6 kg over 12 weeks in responders), appreciate that individual response varies significantly, commit to proper nutrition and exercise foundations, and accept that the peptide is used for research purposes under medical supervision
It is commonly explored for its relationship to NNMT activity, with research interest centered on how that pathway may influence fat metabolism, lean mass support, and energy balance
View our intramuscular injection guide
Important Note This content is intended for therapeutic educational purposes only and does not constitute medical advice, diagnosis, or treatment